Article Text

PDF
Letters
Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance
  1. A Messori,
  2. S Trippoli
  1. Laboratory of Pharmacoeconomics of the Italian Society of Hospital Pharmacists, Milan, Italy
  1. Dr A Messori, c/o Pharmaceutical Service, Italy; andreamessori{at}interfree.it

Statistics from Altmetric.com

To the editor: The guidance on drug-eluting stents by Richarson et al1is a typical application of the value-based approach that NICE systematically uses to examine costs and benefits of innovative treatments.

In countries like Italy, where national regulatory agencies do not use any value-based approach in their approval process, appraisals on whether or not innovative interventions are value for money are left to individual researchers …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.